Isnani, Ayang .

HRN: 26-05-21  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2024
CEFUROXIME 1.5GM (VIAL)
10/15/2024
10/16/2024
IV
1.5g
PTOR
Elective CS
Waiting Final Action 
10/15/2024
CEFUROXIME 500MG (TAB)
10/15/2024
10/22/2024
PO
500mg
BID
S/P LTCS
Waiting Final Action 
10/15/2024
MUPIROCIN 2%, 15G (TUBE)
10/15/2024
10/20/2024
TOPICAL
2%
BID
S/P LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: